Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Continuing to exceed industry expectations, CoreRx, a Tampa-based pharmaceutical development company, added two new critical roles to their growing organization; Director of Commercial Manufacturing, and a Manager of Marketing & Strategic Development...
read more
CoreRx and Aimmune Therapeutics announced their expansion of Myerlake-3.
read more
Wednesday, September 25, 2013
CoreRx, a leader in early pharmaceutical development services, recently announced the addition of Dr. Janice Cacace, who will serve as Director, Formulation Development
read more
CoreRx, Inc., an industry-leading CDMO with formulation development, analytical services and GMP manufacturing sites in Clearwater, Florida and San Rafael, California announces Michael Grass, Ph.D. has joined CoreRx as Senior Director of Product ...
read more
Monday, November 05, 2018
CoreRx has announced the completed installation of the Optel Line Master Serialization and Aggregation System for support of commercial liquid dosage form manufacturing.
read more
CoreRx, Inc. announced the appointment of Dan Dobry as Chief Strategy Officer and a member of CoreRx’s Executive Leadership Team. Dan will report to CoreRx’s Chief Executive Officer, Ajay Damani.
read more
CoreRx, Inc., a CDMO with formulation, development and GMP manufacturing sites in Clearwater, Florida and San Rafael, California, is pleased to announce the appointment of Sitakant (S.K.) Chaudhury as Chief Financial Officer and as a member of CoreRx...
read more
CoreRx, Inc., an industry leading CDMO with formulation development, analytical services and GMP manufacturing sites in Clearwater, Florida and San Rafael, California,
read more
Wednesday, January 31, 2018
A group of industry investors has announced the acquisition of CorePharma, its facilities and equipment in Middlesex, NJ from Impax Laboratories.
read more
CordenPharma announced the signing of an amendment to their existing manufacturing agreement with Moderna, a clinical stage biotechnology company.
read more
CordenPharma announced the signing of an amendment to their existing manufacturing agreement with Moderna to create a new generation of transformative medicines for patients.
read more
CordenPharma and GE Healthcare’s Dharmacon business have entered a collaboration to create an end-to-end solution for oligonucleotide-based drug discovery.
read more
CordenPharma Plankstadt announced the design and installment of a new manufacturing line dedicated to producing Veterinary Drug Products for 500kg scale batch sizes to supply a complex product for application in the veterinary health market.
read more
Thursday, August 29, 2013
International Chemical Investors Group (ICIG) and the Solvay Group have entered into an agreement under which ICIG will acquire Peptisyntha SA, the Brussels, Belgium, based custom manufacturer of peptides for pharmaceutical use. Upon closing of the ...
read more
With an organic capex investment in Two Phases, the strategic expansion provides biotech and pharma customers with a fully-integrated API to Drug Product service offering organized under a new Oligonucleotides Platform.
read more